Mariner, LLC Gamida Cell Ltd. Transaction History

Mariner, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.04 - $0.46 $36,067 - $414,773	-901,682 Reduced 88.13%	121,482 $4,000
Q4 2023 Feb 14, 2024	BUY	$0.25 - $1.02 $73,630 - $300,412	294,522 Added 40.42%	1,023,164 $419,000
Q3 2023 Nov 13, 2023	BUY	$0.85 - $1.87 $475 - $1,045	559 Added 0.08%	728,642 $750,000
Q2 2023 Aug 11, 2023	BUY	$0.73 - $2.37 $3,862 - $12,539	5,291 Added 0.73%	728,083 $1.41 Million
Q1 2023 May 12, 2023	BUY	$0.68 - $1.71 $1,277 - $3,213	1,879 Added 0.26%	722,792 $585,000
Q4 2022 Feb 14, 2023	BUY	$1.15 - $2.1 $5,885 - $10,747	5,118 Added 0.72%	720,913 $930,000
Q3 2022 Nov 10, 2022	BUY	$1.53 - $3.39 $27,939 - $61,904	18,261 Added 2.62%	715,795 $1.14 Million
Q2 2022 Aug 15, 2022	BUY	$1.73 - $4.29 $131,826 - $326,898	76,200 Added 12.26%	697,534 $1.24 Million
Q1 2022 May 13, 2022	BUY	$2.22 - $4.47 $105,643 - $212,713	47,587 Added 8.29%	621,334 $2.58 Million
Q4 2021 Feb 14, 2022	BUY	$2.2 - $4.46 $240,460 - $487,478	109,300 Added 23.53%	573,747 $1.46 Million
Q3 2021 Nov 15, 2021	BUY	$3.85 - $6.44 $399,114 - $667,609	103,666 Added 28.73%	464,447 $1.82 Million
Q2 2021 Aug 24, 2021	BUY	$5.85 - $8.33 $940,568 - $1.34 Million	160,781 Added 80.39%	360,781 $2.31 Million
Q1 2021 May 07, 2021	BUY	$7.8 - $12.43 $1.56 Million - $2.49 Million	200,000 New	200,000 $1.62 Million
Q4 2020 Feb 16, 2021	SELL	$4.07 - $11.0 $455,026 - $1.23 Million	-111,800 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$3.93 - $4.59 $439,374 - $513,162	111,800 New	111,800 $464,000

2.2K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

Stay updated on Mariner, LLC with notifications on news.